A study for a 23 year old woman who takes Nevirapine - from FDA reports


Summary

881 females aged 23 (±5) who take the same drug are studied. This is a personalized study for a 23 year old female patient who has . The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Oct, 13, 2017

881 females aged 23 (±5) who take Nevirapine are studied.


Number of reports submitted per year:

Nevirapine for a 23-year old woman.

Information of the patient in this study:

  • Age: 23
  • Gender: female
  • Conditions:
  • Drugs taken:
    • Nevirapine (nevirapine)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • complications of maternal exposure to therapeutic drugs
  • drug exposure during pregnancy
  • abortion spontaneous
  • maternal drugs affecting foetus
  • fever
  • erythema multiforme
  • nausea and vomiting
  • birth control
  • rashes
  • headache
1 - 6 months:
  • stillbirth
  • drug exposure during pregnancy
  • abortion spontaneous
  • maternal drugs affecting foetus
  • complications of maternal exposure to therapeutic drugs
  • erythema multiforme
  • fever
  • birth control
  • chorioamnionitis
  • premature labor
6 - 12 months:
  • malaise
  • anaemia
  • drug exposure during pregnancy
  • pulmonary tuberculosis
  • weakness
  • escherichia urinary tract infection
  • agranulocytosis
  • weight decreased
  • chest pain
  • pancytopenia
1 - 2 years:
  • birth control
  • drug exposure during pregnancy
  • stillbirth
2 - 5 years:
  • aseptic necrosis
  • depression
  • suicidal ideation
  • hypothyroidism
  • maternal exposure during pregnancy
  • pathogen resistance
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • drug exposure during pregnancy
  • fever
  • birth control
  • abortion spontaneous
  • complications of maternal exposure to therapeutic drugs
  • abortion induced
  • erythema multiforme
  • rashes
  • nausea and vomiting
  • stillbirth

Top conditions involved for these people *:

  • Birth Control (27 people, 3.06%)
  • Preventive Health Care (18 people, 2.04%)
  • Acne (18 people, 2.04%)
  • Tuberculosis (14 people, 1.59%)
  • Depression (14 people, 1.59%)

Top co-used drugs for these people *:

  • Combivir (207 people, 23.50%)
  • Lamivudine (103 people, 11.69%)
  • Epivir (99 people, 11.24%)
  • Zerit (87 people, 9.88%)
  • Stavudine (83 people, 9.42%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

Related studies: